Pregnant women and infants are at risk should they contract mpox but there are no approved vaccines for this population.

The registrational trial is expected to support the Bavarian’s mpox/smallpox vaccine use in children between 2 and 11 years ...

Results from this study could support an extension of the current approval of MVA-BN to include children from 2 years of age ...

Paul Chaplin, President & CEO of Bavarian Nordic, said: "Children remain highly vulnerable to mpox infections in the ongoing outbreak in Africa, highlighting the importance and urgency to broaden ...

An initial 899,000 vaccine doses have been allocated for 9 countries across Africa that have been hit hard by the current mpox surge, the WHO and other health organisations said on Wednesday.

Last week African countries reported 2,532 new mpox cases, mostly in the Democratic Republic of the Congo (DRC) and Burundi, ...

One of the World Health Organization’s most important jobs is managing viral outbreaks. The rapid spread of mpox, a disease related to smallpox, is a reminder of its shortcomings. The WHO has ...

Revenue from the Travel Health business is now expected at approximate First award under UNICEF emergency tender to secure availability of mpox vaccines for Africa COPENHAGEN, Denmark, September 26, ...

raging through the Congo and other countries in Central Africa, younger people have become markedly vulnerable to infection. While Bavarian Nordic’s vaccine Jynneos is approved in several ...

In September, Bavarian Nordic said it would prioritise the production of two million mpox vaccines by the end of this year to help fight the disease in Africa. The Swiss biotech has already shipped ...

Africa must boost local vaccine manufacturing to beat mpox and ensure long-term health security, say public health leaders.